Masahiro Sekimizu

6PUBLICATIONS
15CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedNeonatologyInfant and child healthAutoimmunityAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 13, 2025
Localized Lymphoblastic Lymphoma in Children and Adolescents: Results of the LLB-NHL03 Trial-A Report From the Japan Children's Cancer Group.

Masahiro Sekimizu, Tomoyuki Watanabe, Hiroko Fukushima

|Mar 20, 2024
Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20).

Masahiro Sekimizu, Reiji Fukano, Yuhki Koga

|Dec 19, 2023
Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.

Tetsuya Mori, Tomoo Osumi, Akiko Kada

|Mar 02, 2023
Non-germinal center B-cell subtype of pediatric diffuse large B-cell lymphoma in Japan: A retrospective cohort study.

Daiki Hori, Ryoji Kobayashi, Atsuko Nakazawa

|Apr 12, 2018
Efficacy and safety of administering pediatric treatment to adolescent patients with mature B-cell non-Hodgkin lymphoma within the Japanese Pediatric Leukemia/Lymphoma Study Group clinical trial.

Masahiro Sekimizu, Hiroya Hashimoto, Tetsuya Mori

|Feb 03, 2018
Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol.

Masahiro Sekimizu, Akihiro Iguchi, Tetsuya Mori

Pageof 1

Frequent Collaborators

4 joint publications

Ryoji Kobayashi

2 joint publications

Tomoo Osumi

1 joint publications

Daiki Hori

1 joint publications

Tetsuya Mori